Clinical Trial Update: Inaticabtagene Autoleucel Injection Treatment for Adult Relapsed or Refractory Acute Lymphocytic Leukemia

View source ↗

Summary

The trial update indicates that Inaticabtagene Autoleucel is being studied for adults with relapsed or refractory B-cell acute lymphoblastic leukemia and is cur…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Acute Lymphoblastic Leukemia

Drugs mentioned

• Inaticabtagene Autoleucel

Snippet

Sponsor: Juventas Cell Therapy Ltd. | Conditions: B-cell Acute Lymphoblastic Leukemia | Status: RECRUITING